BioMarin focuses on developing first-in-class and best-in-class therapies that provide meaningful advances to people who live with serious and life-threatening rare genetic diseases. The company relentlessly pursues breakthrough science that has the potential to change the course of disease. The employees of BioMarin are passionate and dedicated to advancing the standard of care in the rare disease communities they serve. Follow BioMarin on Facebook or YouTube to learn more.